NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
record initialized not assigned to examiner
on 07 Nov 2024
Last Applicant/ Owned by
600 Delran Pkwy, Unit C
Delran
NJ
08075
Serial Number
98841106 filed on 07th Nov 2024
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
CARNEGIE PHARMA
Dietary supplements for humans; Glaucoma agents; Medicines for the treatment of gastrointestinal diseases; Nutritional supplements; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, mu Read More
Classification Information
Class [005]
Pharmaceutical Products
Dietary supplements for humans; Glaucoma agents; Medicines for the treatment of gastrointestinal diseases; Nutritional supplements; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical products for the prevention and treatment of cancer; Thyroid and para-thyroid hormone preparations; Vitamin and mineral preparations for medical use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98841106
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th Nov 2024 | NEW APPLICATION ENTERED |